More European funds for Israeli cancer testing

I reported previously (see here) on Israel’s Nucleix and its innovative blood and urine tests for early-stage cancer diagnostics. Nucleix has just received a grant of 2.5 million Euros from the EU’s Horizon 2020 research and innovation program – its second grant in two years.,7340,L-3743363,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *